Nucleus basalis of Meynert neuronal activity in Parkinson's disease
- PMID: 30797189
- DOI: 10.3171/2018.11.JNS182386
Nucleus basalis of Meynert neuronal activity in Parkinson's disease
Abstract
Objective: Neuronal loss within the cholinergic nucleus basalis of Meynert (nbM) correlates with cognitive decline in dementing disorders such as Alzheimer's disease and Parkinson's disease (PD). In nonhuman primates, the nbM firing pattern (5-40 Hz) has also been correlated with working memory and sustained attention. In this study, authors performed microelectrode recordings of the globus pallidus pars interna (GPi) and the nbM immediately prior to the implantation of bilateral deep brain stimulation (DBS) electrodes in PD patients to treat motor symptoms and cognitive impairment, respectively. Here, the authors evaluate the electrophysiological properties of the nbM in patients with PD.
Methods: Five patients (4 male, mean age 66 ± 4 years) with PD and mild cognitive impairment underwent bilateral GPi and nbM DBS lead implantation. Microelectrode recordings were performed through the GPi and nbM along a single trajectory. Firing rates and burst indices were characterized for each neuronal population with the patient at rest and performing a sustained-attention auditory oddball task. Action potential (AP) depolarization and repolarization widths were measured for each neuronal population at rest.
Results: In PD patients off medication, the authors identified neuronal discharge rates that were specific to each area populated by GPi cells (92.6 ± 46.1 Hz), border cells (34 ± 21 Hz), and nbM cells (13 ± 10 Hz). During the oddball task, firing rates of nbM cells decreased (2.9 ± 0.9 to 2.0 ± 1.1 Hz, p < 0.05). During baseline recordings, the burst index for nbM cells (1.7 ± 0.6) was significantly greater than those for GPi cells (1.2 ± 0.2, p < 0.05) and border cells (1.1 ± 0.1, p < 0.05). There was no significant difference in the nbM burst index during the oddball task relative to baseline (3.4 ± 1.7, p = 0.20). With the patient at rest, the width of the depolarization phase of APs did not differ among the GPi cells, border cells, and nbM cells (p = 0.60); however, during the repolarization phase, the nbM spikes were significantly longer than those for GPi high-frequency discharge cells (p < 0.05) but not the border cells (p = 0.20).
Conclusions: Neurons along the trajectory through the GPi and nbM have distinct firing patterns. The profile of nbM activity is similar to that observed in nonhuman primates and is altered during a cognitive task associated with cholinergic activation. These findings will serve to identify these targets intraoperatively and form the basis for further research to characterize the role of the nbM in cognition.
Keywords: AP = action potential; BK = big-conductance calcium-activated potassium; DBS = deep brain stimulation; EEG = electroencephalography; GABAergic = pertaining to or affecting the neurotransmitter gamma-aminobutyric acid; GPi = globus pallidus pars interna; HFD = high-frequency discharge; MCP = midcommissural point; PD = Parkinson’s disease; PD-MCI = mild cognitive impairment in PD; PDD = PD dementia; Parkinson’s disease; functional neurosurgery; microelectrode recording; nbM = nucleus basalis of Meynert; nucleus basalis of Meynert.
Similar articles
-
Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson's disease dementia.Neuroimage. 2020 Nov 1;221:117184. doi: 10.1016/j.neuroimage.2020.117184. Epub 2020 Jul 22. Neuroimage. 2020. PMID: 32711059 Free PMC article.
-
Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition.Mov Disord. 2022 Mar;37(3):635-640. doi: 10.1002/mds.28870. Epub 2021 Nov 22. Mov Disord. 2022. PMID: 34806782 Clinical Trial.
-
Simultaneous Stimulation of the Globus Pallidus Interna and the Nucleus Basalis of Meynert in the Parkinson-Dementia Syndrome.Dement Geriatr Cogn Disord. 2019;47(1-2):19-28. doi: 10.1159/000493094. Epub 2019 Jan 10. Dement Geriatr Cogn Disord. 2019. PMID: 30630160
-
Deep brain stimulation for dementias.Neurosurg Focus. 2018 Aug;45(2):E8. doi: 10.3171/2018.5.FOCUS18172. Neurosurg Focus. 2018. PMID: 30064323 Review.
-
Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease.J Neurochem. 2025 Feb;169(2):e16264. doi: 10.1111/jnc.16264. Epub 2024 Nov 18. J Neurochem. 2025. PMID: 39556446 Free PMC article. Review.
Cited by
-
State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities.Neurosci Biobehav Rev. 2023 Jan;144:104998. doi: 10.1016/j.neubiorev.2022.104998. Epub 2022 Dec 13. Neurosci Biobehav Rev. 2023. PMID: 36526031 Free PMC article. Review.
-
Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders.Bioelectron Med. 2021 Mar 30;7(1):4. doi: 10.1186/s42234-021-00065-9. Bioelectron Med. 2021. PMID: 33781350 Free PMC article. Review.
-
The role of the nucleus basalis of Meynert in neuromodulation therapy: a systematic review from the perspective of neural network oscillations.Front Aging Neurosci. 2024 Apr 8;16:1376764. doi: 10.3389/fnagi.2024.1376764. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38650866 Free PMC article. Review.
-
Mapping striatal functional gradients and associated gene expression in Parkinson's disease with continuous cognitive impairment.NPJ Parkinsons Dis. 2025 May 28;11(1):138. doi: 10.1038/s41531-025-01002-2. NPJ Parkinsons Dis. 2025. PMID: 40425604 Free PMC article.
-
Exploring reward-related attention selectivity deficits in Parkinson's disease.Sci Rep. 2021 Sep 21;11(1):18751. doi: 10.1038/s41598-021-97526-7. Sci Rep. 2021. PMID: 34548517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous